Arrayit Corporation (ARYC)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2014 | -3.62 Million USD | -364.47% |
| 2013 | -779.93 Thousand USD | 61.92% |
| 2012 | -2.04 Million USD | -3459.95% |
| 2011 | 60.95 Thousand USD | 101.97% |
| 2010 | -3.09 Million USD | 43.26% |
| 2009 | -5.45 Million USD | -59574.3% |
| 2008 | -9145.00 USD | 99.6% |
| 2007 | -2.29 Million USD | 60.84% |
| 2006 | -5.86 Million USD | -131.02% |
| 2005 | -2.53 Million USD | 38.93% |
| 2004 | -4.15 Million USD | 89.48% |
| 2003 | -39.48 Million USD | -1356.11% |
| 2002 | -2.71 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2015 Q3 | -3.19 Million USD | -2086.68% |
| 2015 Q1 | -882.05 Thousand USD | 64.8% |
| 2015 Q2 | -146.22 Thousand USD | 83.42% |
| 2014 Q1 | -326.14 Thousand USD | 67.12% |
| 2014 FY | -3.62 Million USD | -364.47% |
| 2014 Q4 | -2.5 Million USD | -566.43% |
| 2014 Q3 | -376.01 Thousand USD | 9.27% |
| 2014 Q2 | -414.44 Thousand USD | -27.07% |
| 2013 FY | -779.93 Thousand USD | 61.92% |
| 2013 Q4 | -992 Thousand USD | -4488.43% |
| 2013 Q1 | 206.66 Thousand USD | 125.29% |
| 2013 Q3 | 22.6 Thousand USD | 200.41% |
| 2013 Q2 | -22.51 Thousand USD | -110.89% |
| 2012 Q4 | -817.07 Thousand USD | -6933.45% |
| 2012 Q1 | -156.57 Thousand USD | -186.63% |
| 2012 FY | -2.04 Million USD | -3459.95% |
| 2012 Q3 | -11.61 Thousand USD | 81.45% |
| 2012 Q2 | -62.62 Thousand USD | 60.01% |
| 2011 Q4 | 180.73 Thousand USD | 414.7% |
| 2011 FY | 60.95 Thousand USD | 101.97% |
| 2011 Q2 | -92.22 Thousand USD | -408.75% |
| 2011 Q3 | -57.43 Thousand USD | 37.73% |
| 2011 Q1 | 29.87 Thousand USD | 102.6% |
| 2010 Q1 | -551.52 Thousand USD | 89.76% |
| 2010 FY | -3.09 Million USD | 43.26% |
| 2010 Q4 | -1.15 Million USD | -627.76% |
| 2010 Q3 | -158.11 Thousand USD | 87.21% |
| 2010 Q2 | -1.23 Million USD | -124.14% |
| 2009 FY | -5.45 Million USD | -59574.3% |
| 2009 Q2 | -2045.00 USD | 98.01% |
| 2009 Q4 | -5.38 Million USD | -15398.19% |
| 2009 Q3 | 35.21 Thousand USD | 1822.2% |
| 2009 Q1 | -102.52 Thousand USD | -176.42% |
| 2008 Q3 | -156.46 Thousand USD | -155.62% |
| 2008 FY | -9145.00 USD | 99.6% |
| 2008 Q4 | 134.15 Thousand USD | 185.75% |
| 2008 Q1 | -179.67 Thousand USD | 95.29% |
| 2008 Q2 | 281.28 Thousand USD | 256.55% |
| 2007 Q1 | 818.78 Thousand USD | 129.51% |
| 2007 FY | -2.29 Million USD | 60.84% |
| 2007 Q4 | -3.81 Million USD | -1481.21% |
| 2007 Q3 | -241.39 Thousand USD | -125.56% |
| 2007 Q2 | 944.56 Thousand USD | 15.36% |
| 2006 Q2 | -798.11 Thousand USD | -21.08% |
| 2006 Q3 | 1.4 Million USD | 275.83% |
| 2006 FY | -5.86 Million USD | -131.02% |
| 2006 Q4 | -2.77 Million USD | -297.68% |
| 2006 Q1 | -659.14 Thousand USD | -252.27% |
| 2005 Q1 | -1.6 Million USD | 35.25% |
| 2005 Q4 | -187.11 Thousand USD | 46.63% |
| 2005 Q3 | -350.62 Thousand USD | 10.85% |
| 2005 FY | -2.53 Million USD | 38.93% |
| 2005 Q2 | -393.28 Thousand USD | 75.51% |
| 2004 Q1 | -515.06 Thousand USD | 98.58% |
| 2004 Q4 | -2.48 Million USD | -426.43% |
| 2004 FY | -4.15 Million USD | 89.48% |
| 2004 Q3 | -471.17 Thousand USD | 31.45% |
| 2004 Q2 | -687.33 Thousand USD | -33.45% |
| 2003 Q1 | -1.12 Million USD | -187.55% |
| 2003 Q4 | -36.37 Million USD | -3269.52% |
| 2003 Q3 | -1.07 Million USD | -18.8% |
| 2003 FY | -39.48 Million USD | -1356.11% |
| 2003 Q2 | -908.76 Thousand USD | 18.98% |
| 2002 Q4 | -390.06 Thousand USD | 79.35% |
| 2002 Q1 | -248.43 Thousand USD | 0.0% |
| 2002 Q3 | -1.88 Million USD | 0.0% |
| 2002 FY | -2.71 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | -191.668% |
| Atlantic International Corp. | -5.73 Million USD | 36.807% |
| Biocept, Inc. | -31.98 Million USD | 88.674% |
| Bioqual, Inc. | -19.63 Thousand USD | -18346.471% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | -369.152% |
| DermTech, Inc. | -103.73 Million USD | 96.508% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 100.146% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 82.609% |
| iMD Companies, Inc. | -175.44 Thousand USD | -1964.748% |
| IDenta Corp. | -1499.00 USD | -241562.308% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 229.191% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 9462.931% |
| InVitro International | -25.33 Thousand USD | -14196.215% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | 49.136% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -6133.683% |
| Medical Imaging Corp. | -819.48 Thousand USD | -342.051% |
| NovelStem International Corp. | -3.52 Million USD | -2.743% |
| Optigenex Inc. | 1.39 Million USD | 360.456% |
| PharmChem, Inc. | 973.14 Thousand USD | 472.248% |
| Proteome Sciences plc | -1.62 Million USD | -123.474% |
| Response Genetics, Inc | -21.37 Million USD | 83.054% |
| Rennova Health, Inc. | -1.4 Million USD | -157.001% |
| RushNet, Inc. | -684.7 Thousand USD | -429.063% |
| ScreenPro Security Inc. | -2.59 Million USD | -39.735% |
| Stella Diagnostics Inc. | -11.42 Million USD | 68.298% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | 53.238% |
| Todos Medical Ltd. | -9.74 Million USD | 62.838% |